"Semaglutide is expected to become patent-free in the United States no earlier than December 2031" [1].
We could probably strike a volume deal for ~$200 for 5 years and then $75 (the upper end of your study’s estimate for manufacturing cost) for another 5.
"Semaglutide is expected to become patent-free in the United States no earlier than December 2031" [1].
We could probably strike a volume deal for ~$200 for 5 years and then $75 (the upper end of your study’s estimate for manufacturing cost) for another 5.
[1] https://www.drugpatentwatch.com/p/tradename/OZEMPIC